Seraprevir and sofosbuvir for treatment of chronic hepatitis C virus infection: A single-arm, open-label, phase 3 trial.

J Gastroenterol Hepatol · 2021 · PMC8518536 · PMID 33491236

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

FibroScan also showed a trend in improved liver stiffness modulus (LSM); the mean reduction in the value of LSM was 1.10 KPa from the baseline to post‐treatment week 12 (6.53 kPa vs 5.42 kPa), as shown in Figure 2 .

also in 53,322 other papers

a significant trendno p-value reported

General liver function tests, including alanine aminotransferase (ALT) and aspartate aminotransferase (AST), showed a significant trend of normalization throughout the study period.

also in 9,775 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.